Will These Biotech Stocks Get Approved By The FDA?

We are well into the second half of 2017. As yet another month comes to an end, let’s take a look back at some of the FDA approval announcements that hit the headlines in July.

Endari, approved on July 7, 2017 for patients with sickle cell disease, marks the first approval for this rare blood disorder in nearly 20 years. Endari is manufactured by privately-held Emmaus Medical Inc.

Health care giant Johnson & Johnson subsidiary Janssen Biotech Inc.’s Tremfya was approved for the treatment of adult patients with moderate-to-severe plaque psoriasis on July 13, 2017. This drug becomes the first and only approved biologic therapy that selectively blocks only IL-23, a cytokine that plays a key role in plaque psoriasis.

On July 17, 2017, the FDA approved Puma Biotechnology Inc.’s (PBYI) Nerlynx, the first extended adjuvant therapy for early-stage, HER2-postive breast cancer.

Another new drug that was given thumbs up by the FDA is Gilead Sciences Inc.’s (GILD) Vosevi for hepatitis C, approved on July 18, 2017. Vosevi is the first treatment approved for patients who have been previously treated with the direct-acting antiviral drug Sofosbuvir or other drugs for HCV that inhibit a protein called NS5A.

Now, let’s take a look at the biotech stocks awaiting word from the FDA in August.Aspect Imaging Ltd’s Embrace Neonatal MRI System received FDA clearance on July 20, 2017, becoming the first neonatal magnetic resonance imaging device to get a regulatory green light.

Practice trading these Biotech Stocks on WSS now!

Gilead Sciences Inc.’s (GILD)

Johnson & Johnson (JNJ)

 

First Seen on RTTNews

January 2, 2021 Update: We have just announced our BEST STOCK NEWSLETTER of 2020 AWARD!

CLICK HERE to find out which stock newsletter was up 78% in 2020 (and whose 2019 picks are now up 113%).

*** Our Award for BEST STOCK NEWSLETTER of 2020 ALERT ***

Updated January 2, 2021

At WallStreetSurvivor, we subscribe to dozens stock recommendation and advisory newsletters. There is ONE newsletter that is constantly outperforming all of the others--The Motley Fool Stock Advisor.

Five of their 2020 stock picks have doubled and the average return of all 24 of their stock picks for 2020 is up 78%!

We have been tracking ALL of the Motley Fool stock picks since January 2016. That's 5 years and 120 stock picks. As of Friday, January 1, 2021 the Motley Fool's January stock pick (TSLA) is up 720%, their March pick (ZM) is up 172%, their April pick of SHOP is up 226% and their June pick CRWD is up 120%; and another two have more than doubled. In addition, 10 of their 2019, 12 of their 2018, 11 of their 2017, 15 of their 2016. Most impressively, over the last 5 years that we have been tracking every recommendation, their average stock pick is up 209%--tht means over the last 5 years their stock picks, on average, have TRIPLED!

Now no one can guarantee that their next picks will be as strong, but our 5 years of experience has been super-profitable. The important thing about the Fool stock picks is you have to buy them the day they are recommended because they usually pop 5-10% in the first 72 hours after the release their recommendation. You sure don’t want to risk missing out on their next pick.

Normally the Fool service is priced at $199 per year but they are currently offering a NEW SUBSCRIBER DISCOUNT that allows you to get theiir next 24 stock picks for just $99/year. HERE is the LINK to visit their New Subscriber Discount page.

CLICK HERE to get access to all The Motley Fool’s Stock Picks and their next 12 months of picks for just $99 per Year! 



GET UP TO $1,000 IN FREE STOCK

WHEN YOU OPEN A ROBINHOOD BROKERAGE ACCOUNT

Robinhood was the first brokerage site to NOT charge commissions when they opened in 2013. They just past 10,000,000 accounts and to celebrate they are offering up to $1,000 in free stock when you open a new account.

Here’s the details: You must click on a special promo link to open your new Robinhood account. Then when you fund your account with at least $10, you will receive one stock valued between $5 and $500. Then, you will get a link to share with your friends. Every time one of your friends opens an account, you will receive another free stock valued between $5 and $500. Click here to learn more about this Special Robinhood offer.

Claim your free stock NOW (before it’s too late)



Comments are closed.